Last updated: January 13, 2025
Sponsor: CND Life Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sleep Disorders
Treatment
N/AClinical Study ID
NCT06621602
MJFF-025208
Ages 50-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and female 50 to 100 years of age
Clinical confirmed diagnosis of Parkinson's disease or REM Sleep Behavior
Exclusion
Exclusion Criteria:
Clinical evidence of severe vascular disease (history of ulceration, poor woundhealing or vascular claudication)
History of allergic reaction to Lidocaine for local anesthesia needed for skinbiopsies
Use of blood thinners (Plavix or Aspirin used separately is allowed)
Significantly impaired wound healing or history of scarring or keloid formation
Study Design
Total Participants: 100
Study Start date:
December 17, 2024
Estimated Completion Date:
April 30, 2026
Study Description
Connect with a study center
CND Life Sciences
Scottsdale, Arizona 85258
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.